Skip to content

Is Levothyroxine recalled?

173 FDA recalls mention Levothyroxine. The most recent are listed below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Levothyroxine.

Class II · Moderate risk Terminated Apr 30, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b) 1000-count…

Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.

King Legacy, a wholly owned subsidiary of Pfizer NDC 60793-859-01 D-430-2013

Class II · Moderate risk Terminated Apr 30, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 150 mcg, packaged in a) 100-count bottles (NDC 60793-858-01) and b) 1000-count…

Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.

King Legacy, a wholly owned subsidiary of Pfizer NDC 60793-858-01 D-429-2013

Class II · Moderate risk Terminated Apr 30, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b) 1000-count…

Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.

King Legacy, a wholly owned subsidiary of Pfizer NDC 60793-857-01 D-428-2013

Class II · Moderate risk Terminated Apr 30, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 125 mcg, packaged in a) 100-count bottles (NDC 60793-856-01) and b) 1000-count…

Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.

King Legacy, a wholly owned subsidiary of Pfizer NDC 60793-856-01 D-427-2013

Class II · Moderate risk Terminated Apr 30, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 112 mcg, packaged in a) 100-count bottles (NDC 60793-855-01) and b) 1000-count…

Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.

King Legacy, a wholly owned subsidiary of Pfizer NDC 60793-855-01 D-426-2013

Class II · Moderate risk Terminated Apr 30, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 100 mcg, packaged in a) 100-count bottles (NDC 60793-854-01) and b) 1000-count…

Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.

King Legacy, a wholly owned subsidiary of Pfizer NDC 60793-854-01 D-425-2013

Class II · Moderate risk Terminated Apr 30, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 88 mcg, packaged in a) 100-count bottles (NDC 60793-853-01) and b) 1000-count…

Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.

King Legacy, a wholly owned subsidiary of Pfizer NDC 60793-853-01 D-424-2013

Class II · Moderate risk Terminated Apr 30, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 75 mcg, packaged in a) 100-count bottles (NDC 60793-852-01) and b) 1000-count…

Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.

King Legacy, a wholly owned subsidiary of Pfizer NDC 60793-852-01 D-423-2013

Class II · Moderate risk Terminated Apr 30, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and b) 1000-count…

Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.

King Legacy, a wholly owned subsidiary of Pfizer NDC 60793-851-01 D-422-2013

Class II · Moderate risk Terminated Apr 30, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 25 mcg, packaged in a) 100-count bottles (NDC 60793-850-01) and b) 1000-count…

Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.

King Legacy, a wholly owned subsidiary of Pfizer NDC 60793-850-01 D-421-2013

Class II · Moderate risk Terminated Apr 1, 2013

Levothroid (levothyroxine sodium tablets, USP), 200 mcg, RX only, 100 tablets per bottle. Manufactured for Forest…

Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not…

Lloyd Inc. of Iowa NDC 0456-1327-01 D-451-2013

Class II · Moderate risk Terminated Apr 1, 2013

Levothroid (levothyroxine sodium tablets, USP), 175 mcg, RX only, 100 tablets per bottle, Manufactured for Forest…

Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not…

Lloyd Inc. of Iowa NDC 0456-1326-01 D-450-2013

Class II · Moderate risk Terminated Apr 1, 2013

Levothroid (levothyroxine sodium tablets, USP), 150 mcg, RX only, 100 tablets per bottle, Manufactured for Forest…

Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not…

Lloyd Inc. of Iowa NDC 0456-1325-01 D-449-2013

Class II · Moderate risk Terminated Apr 1, 2013

Levothroid (levothyroxine sodium tablets, USP), 137 mcg, RX only, 100 tablets per bottle, Manufactured for Forest…

Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not…

Lloyd Inc. of Iowa NDC 0456-1331-01 D-448-2013

Class II · Moderate risk Terminated Apr 1, 2013

Levothroid (levothyroxine sodium tablets, USP) , 125 mcg, RX only, 100 tablets per bottle, Manufactured for Forest…

Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not…

Lloyd Inc. of Iowa NDC 0456-1324-01 D-447-2013

Class II · Moderate risk Terminated Apr 1, 2013

Levothroid (levothyroxine sodium tablets, USP), 112 mcg, RX only, 100 tablets per bottle, Manufactured for Forest…

Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not…

Lloyd Inc. of Iowa NDC 0456-1330-01 D-446-2013

Class II · Moderate risk Terminated Apr 1, 2013

Levothroid (levothyroxine sodium tablets, USP), 100 mcg, RX only, 100 tablets per bottle, Manufactured for Forest…

Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not…

Lloyd Inc. of Iowa NDC 0456-1323-01 D-445-2013

Class II · Moderate risk Terminated Apr 1, 2013

Levothroid (levothyroxine sodium tablets, USP), 88 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals…

Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not…

Lloyd Inc. of Iowa NDC 0456-1329-01 D-436-2013

Class II · Moderate risk Terminated Apr 1, 2013

Levothroid (levothyroxine sodium tablets, USP) , 75 mcg, RX only, 100 tablets per bottle, Manufactured for Forest…

Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not…

Lloyd Inc. of Iowa NDC 0456-1322-01 D-434-2013

Class II · Moderate risk Terminated Apr 1, 2013

Levothroid (levothyroxine sodium tablets, USP) , 50 mcg, RX only, 100 tablets per bottle, Manufactured for Forest…

Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not…

Lloyd Inc. of Iowa NDC 0456-1321-01 D-432-2013

Class II · Moderate risk Completed Mar 28, 2013

Levoxyl (levothyroxine sodium) tablets, USP 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and b) 1000-count…

Reason Chemical contamination: emission of strong odor after package was opened.

Pfizer Inc. NDC 60793-860-01 D-261-2013

Class II · Moderate risk Completed Mar 28, 2013

Levoxyl (levothyroxine sodium) tablets, USP 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b) 1000-count…

Reason Chemical contamination: emission of strong odor after package was opened.

Pfizer Inc. NDC 60793-859-01 D-260-2013

Class II · Moderate risk Completed Mar 28, 2013

Levoxyl (levothyroxine sodium) tablets, USP 150 mcg, packaged in a) 100-count bottles (NDC 60793-858-01) and b) 1000-count…

Reason Chemical contamination: emission of strong odor after package was opened.

Pfizer Inc. NDC 60793-858-01 D-259-2013

Class II · Moderate risk Completed Mar 28, 2013

Levoxyl (levothyroxine sodium) tablets, USP 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b) 1000-count…

Reason Chemical contamination: emission of strong odor after package was opened.

Pfizer Inc. NDC 60793-857-01 D-258-2013

Class II · Moderate risk Completed Mar 28, 2013

Levoxyl (levothyroxine sodium) tablets, USP 125 mcg, packaged in a) 100-count bottles (NDC 60793-856-01) and b) 1000-count…

Reason Chemical contamination: emission of strong odor after package was opened

Pfizer Inc. NDC 60793-856-01 D-257-2013